Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
IBA-Radcal

Download Mobile App




Fructose Intolerance Is Common in Children with Abdominal Pain

By HospiMedica International staff writers
Posted on 02 Nov 2010
Fructose malabsorption or fructose intolerance is common in children with recurrent or functional abdominal pain.

Fructose intolerance is typically diagnosed by exclusion that once other gastro-intestinal conditions like Crohn's disease and ulcerative colitis are ruled out, a hydrogen breath test is given to the patient. More...
If the patient's breath hydrogen exceeds 20 ppm points above baseline, then the patient is likely to be fructose intolerant.

Scientists at the Mary Bridge Children's Hospital, (Tacoma, WA, USA), investigated a total of 245 patients with unexplained chronic abdominal pain alone or associated with constipation, gas or bloating and/or diarrhea. The ages ranged from 2 to 18 years old, with a median age of 11 and 62.1% were female. The patients received a standard dose of fructose (1 g/kg, to a maximum of 25 g), followed by a breath hydrogen test (BHT), which measured methane levels at 30-minute intervals for 90 minutes. The test for fructose was performed in all patients in the study and it was positive for fructose intolerance in 132 of 245 patients (53.9 %). A total of 113 of 245 (46.1%) of patients had a negative BHT for fructose intolerance. All of the 132 patients with a positive BHT for fructose had a nutritional consult with a registered dietician and were placed on a low-fructose diet. Using a standard pain scale for children, 88 of the 132 patients (67.7%) reported resolution of symptoms on a low-fructose diet.

Daniel Lustig, M.D., a pediatric gastroenterologist at the hospital, said, "Fructose intolerance is more prevalent in teenage girls with chronic abdominal pain. While there is definitely a subset of patients who respond well to a low-fructose diet, it is challenging for patients who are fructose intolerant to maintain, especially teenagers. But the good news is that over half of patients who are fructose intolerant are able to maintain a low-fructose diet and are able to notice an immediate improvement in their symptoms.” The results of the study were unveiled at the American College of Gastroenterology's 75th Annual Scientific meeting, October 15 - 20, 2010, in San Antonio, TX, USA.

Related Links:
Mary Bridge Children's Hospital




Gold Member
POC Blood Gas Analyzer
Stat Profile Prime Plus
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
Surgical Headlight
IsoTorch
Electric Bed
DIXION Intensive Care Bed
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: The fiber in the brain implant is less than half a millimeter thick (Photo courtesy of Peter Aagaard Brixen)

Brain Implant Records Neural Signals and Delivers Precise Medication

Neurological diseases such as epilepsy involve complex interactions across multiple layers of the brain, yet current implants can typically stimulate or record activity from only a single point.... Read more

Patient Care

view channel
Image: The revolutionary automatic IV-Line flushing device set for launch in the EU and US in 2026 (Photo courtesy of Droplet IV)

Revolutionary Automatic IV-Line Flushing Device to Enhance Infusion Care

More than 80% of in-hospital patients receive intravenous (IV) therapy. Every dose of IV medicine delivered in a small volume (<250 mL) infusion bag should be followed by subsequent flushing to ensure... Read more

Business

view channel
Image: Medtronic’s intent to acquire CathWorks follows a 2022 strategic partnership with a co-promotion agreement for the FFRangio System (Photo courtesy of CathWorks)

Medtronic to Acquire Coronary Artery Medtech Company CathWorks

Medtronic plc (Galway, Ireland) has announced that it will exercise its option to acquire CathWorks (Kfar Saba, Israel), a privately held medical device company, which aims to transform how coronary artery... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.